Diligent Pharma

Diligent Pharma is a Quality and Risk Management Organization revolutionizing the clinical trial industry with its central platform for driving speed, efficiency, and high compliance in clinical trial vendor qualification. Established in 2018 and headquartered in the United States, Diligent Pharma's mission is encapsulated in its slogan, "Helping clinical trials start faster with streamlined selection and qualification of clinical research service providers." The company serves as the clinical trial industry's leading vendor qualification ecosystem, connecting pharma and biotech sponsors to a global network of Diligent Qualified GCP and GCLP providers. With a strategic focus on comprehensive, rigorous solutions, Diligent Pharma drives high quality and compliance, expedites vendor qualification, mitigates risks, and reduces costs. These efforts ultimately facilitate the successful and expedient initiation of clinical trials, imbuing sponsors with confidence in the process. The most recent milestone for Diligent Pharma was its $8.27M Series A investment on 15 May 2023. This round of funding was led by prominent investors including PJC, FCA Venture Partners, and GenHenn Venture, underlining the industry's recognition of the company's potential and innovation in addressing critical needs within the pharmaceutical realm.